Effect of Levodopa on Thyroid Function and Prolactin Release
- 1 December 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 38 (12) , 759-760
- https://doi.org/10.1001/archneur.1981.00510120059009
Abstract
• Patients with Parkinson's disease who received a regimen of levodopa at levels that gave good clinical results did not have impaired thyroid function. The response of thyrotropin to intravenous administration of protirelin in these patients was not impaired by long-term levodopa therapy, but the prolactin response at 60 minutes was suppressed only in women. The response of prolactin to protirelin stimulation became similar to that found in both treated and untreatedThis publication has 4 references indexed in Scilit:
- Sinemet® and thyroid function in Parkinson diseaseNeurology, 1979
- INCREASED PROLACTIN AND THYROTROPHIN SECRETION FOLLOWING ORAL METOCLOPRAMIDE: DOSE-RESPONSE RELATIONSHIPSClinical Endocrinology, 1977
- Studies on the Mechanism of the Dopamine-Mediated Inhibition of Prolactin Secretion1Endocrinology, 1974
- CHLORPROMAZINE STIMULATION AND L-DOPA SUPPRESSION OF PLASMA PROLACTIN IN MAN1Journal of Clinical Endocrinology & Metabolism, 1971